APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

AI Clinical Trial Design Software

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global AI Clinical Trial Design Software Industry Growth and Trends Forecast to 2032

Report ID 174539760212 August 2026124 pages

Choose your research edition.

Industry ResearchAI Clinical Trial Design Software Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Clinical Trial Design Software Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal AI Clinical Trial Design Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Clinical Trial Design Software Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Clinical Trial Design Software Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

According to APO Research, the global AI Clinical Trial Design Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for AI Clinical Trial Design Software is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for AI Clinical Trial Design Software is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Clinical Trial Design Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the AI Clinical Trial Design Software market include Cytel, TriNetX, Saama, Simulations Plus, Statsols, ConcertAI, Phesi, Faro Health and QuantHealth, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global AI Clinical Trial Design Software market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The AI Clinical Trial Design Software market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global AI Clinical Trial Design Software market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to AI Clinical Trial Design Software.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global AI Clinical Trial Design Software market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

AI Clinical Trial Design Software Market by Company

Cytel

TriNetX

Saama

Simulations Plus

Statsols

ConcertAI

Phesi

Faro Health

QuantHealth

Unlearn

MMS

Berry Consultants

ZS

Clinion

Nurocor

Lindus Health

TrialKey

Protocol Builder

Medidata

IQVIA

Certara

AI Clinical Trial Design Software Segment by Type

End-to-End Trial Design Platforms

Protocol Authoring and Optimization Software

Trial Simulation and Outcome Prediction Software

Adaptive and Bayesian Design Software

Feasibility and Enrollment Design Software

Synthetic Control and Digital Twin Software

AI Clinical Trial Design Software Segment by Application

Pharmaceutical and Biotechnology Companies

Contract Research Organizations

Medical Device and Diagnostics Companies

Academic and Medical Research Institutions

Government and Nonprofit Research Organizations

Other Clinical Research Organizations

AI Clinical Trial Design Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Clinical Trial Design Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Clinical Trial Design Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Clinical Trial Design Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of AI Clinical Trial Design Software companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global AI Clinical Trial Design Software Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global AI Clinical Trial Design Software Market Size by Region (2021-2026) & (US$ Million) Table 3. Global AI Clinical Trial Design Software Market Share by Region (2021-2026) Table 4. Global AI Clinical Trial Design Software Market Size by Region (2027-2032) & (US$ Million) Table 5. Global AI Clinical Trial Design Software Market Share by Region (2027-2032) Table 6. Global AI Clinical Trial Design Software Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global AI Clinical Trial Design Software Market Size by Type (2021-2026) & (US$ Million) Table 8. Global AI Clinical Trial Design Software Market Size Share by Type (2021-2026) Table 9. Global AI Clinical Trial Design Software Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global AI Clinical Trial Design Software Market Size Share Forecasted by Type (2027-2032) Table 11. North America AI Clinical Trial Design Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America AI Clinical Trial Design Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe AI Clinical Trial Design Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe AI Clinical Trial Design Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific AI Clinical Trial Design Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific AI Clinical Trial Design Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America AI Clinical Trial Design Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America AI Clinical Trial Design Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa AI Clinical Trial Design Software Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa AI Clinical Trial Design Software Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global AI Clinical Trial Design Software Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global AI Clinical Trial Design Software Market Size by Application (2021-2026) & (US$ Million) Table 23. Global AI Clinical Trial Design Software Market Size Share by Application (2021-2026) Table 24. Global AI Clinical Trial Design Software Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global AI Clinical Trial Design Software Market Size Share Forecasted by Application (2027-2032) Table 26. North America AI Clinical Trial Design Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America AI Clinical Trial Design Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe AI Clinical Trial Design Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe AI Clinical Trial Design Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific AI Clinical Trial Design Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific AI Clinical Trial Design Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America AI Clinical Trial Design Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America AI Clinical Trial Design Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa AI Clinical Trial Design Software Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa AI Clinical Trial Design Software Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. AI Clinical Trial Design Software Industry Trends Table 37. AI Clinical Trial Design Software Industry Drivers Table 38. AI Clinical Trial Design Software Industry Opportunities and Challenges Table 39. AI Clinical Trial Design Software Industry Restraints Table 40. Global AI Clinical Trial Design Software Revenue by Company (US$ Million) & (2021-2026) Table 41. Global AI Clinical Trial Design Software Revenue Market Share by Company (2021-2026) Table 42. Global AI Clinical Trial Design Software Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global AI Clinical Trial Design Software Key Company Headquarters & Area Served Table 44. Global AI Clinical Trial Design Software Company, Product Type & Application Table 45. Global AI Clinical Trial Design Software Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global AI Clinical Trial Design Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Cytel Company Information Table 49. Cytel Business Overview Table 50. Cytel AI Clinical Trial Design Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Cytel AI Clinical Trial Design Software Product Portfolio Table 52. Cytel Recent Development Table 53. TriNetX Company Information Table 54. TriNetX Business Overview Table 55. TriNetX AI Clinical Trial Design Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. TriNetX AI Clinical Trial Design Software Product Portfolio Table 57. TriNetX Recent Development Table 58. Saama Company Information Table 59. Saama Business Overview Table 60. Saama AI Clinical Trial Design Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Saama AI Clinical Trial Design Software Product Portfolio Table 62. Saama Recent Development Table 63. Simulations Plus Company Information Table 64. Simulations Plus Business Overview Table 65. Simulations Plus AI Clinical Trial Design Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Simulations Plus AI Clinical Trial Design Software Product Portfolio Table 67. Simulations Plus Recent Development Table 68. Statsols Company Information Table 69. Statsols Business Overview Table 70. Statsols AI Clinical Trial Design Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Statsols AI Clinical Trial Design Software Product Portfolio Table 72. Statsols Recent Development Table 73. ConcertAI Company Information Table 74. ConcertAI Business Overview Table 75. ConcertAI AI Clinical Trial Design Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. ConcertAI AI Clinical Trial Design Software Product Portfolio Table 77. ConcertAI Recent Development Table 78. Phesi Company Information Table 79. Phesi Business Overview Table 80. Phesi AI Clinical Trial Design Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Phesi AI Clinical Trial Design Software Product Portfolio Table 82. Phesi Recent Development Table 83. Faro Health Company Information Table 84. Faro Health Business Overview Table 85. Faro Health AI Clinical Trial Design Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Faro Health AI Clinical Trial Design Software Product Portfolio Table 87. Faro Health Recent Development Table 88. QuantHealth Company Information Table 89. QuantHealth Business Overview Table 90. QuantHealth AI Clinical Trial Design Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. QuantHealth AI Clinical Trial Design Software Product Portfolio Table 92. QuantHealth Recent Development Table 93. Unlearn Company Information Table 94. Unlearn Business Overview Table 95. Unlearn AI Clinical Trial Design Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Unlearn AI Clinical Trial Design Software Product Portfolio Table 97. Unlearn Recent Development Table 98. MMS Company Information Table 99. MMS Business Overview Table 100. MMS AI Clinical Trial Design Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. MMS AI Clinical Trial Design Software Product Portfolio Table 102. MMS Recent Development Table 103. Berry Consultants Company Information Table 104. Berry Consultants Business Overview Table 105. Berry Consultants AI Clinical Trial Design Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Berry Consultants AI Clinical Trial Design Software Product Portfolio Table 107. Berry Consultants Recent Development Table 108. ZS Company Information Table 109. ZS Business Overview Table 110. ZS AI Clinical Trial Design Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. ZS AI Clinical Trial Design Software Product Portfolio Table 112. ZS Recent Development Table 113. Clinion Company Information Table 114. Clinion Business Overview Table 115. Clinion AI Clinical Trial Design Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Clinion AI Clinical Trial Design Software Product Portfolio Table 117. Clinion Recent Development Table 118. Nurocor Company Information Table 119. Nurocor Business Overview Table 120. Nurocor AI Clinical Trial Design Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Nurocor AI Clinical Trial Design Software Product Portfolio Table 122. Nurocor Recent Development Table 123. Lindus Health Company Information Table 124. Lindus Health Business Overview Table 125. Lindus Health AI Clinical Trial Design Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Lindus Health AI Clinical Trial Design Software Product Portfolio Table 127. Lindus Health Recent Development Table 128. TrialKey Company Information Table 129. TrialKey Business Overview Table 130. TrialKey AI Clinical Trial Design Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. TrialKey AI Clinical Trial Design Software Product Portfolio Table 132. TrialKey Recent Development Table 133. Protocol Builder Company Information Table 134. Protocol Builder Business Overview Table 135. Protocol Builder AI Clinical Trial Design Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Protocol Builder AI Clinical Trial Design Software Product Portfolio Table 137. Protocol Builder Recent Development Table 138. Medidata Company Information Table 139. Medidata Business Overview Table 140. Medidata AI Clinical Trial Design Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Medidata AI Clinical Trial Design Software Product Portfolio Table 142. Medidata Recent Development Table 143. IQVIA Company Information Table 144. IQVIA Business Overview Table 145. IQVIA AI Clinical Trial Design Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. IQVIA AI Clinical Trial Design Software Product Portfolio Table 147. IQVIA Recent Development Table 148. Certara Company Information Table 149. Certara Business Overview Table 150. Certara AI Clinical Trial Design Software Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Certara AI Clinical Trial Design Software Product Portfolio Table 152. Certara Recent Development Table 153. North America AI Clinical Trial Design Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. North America AI Clinical Trial Design Software Market Size by Country (2021-2026) & (US$ Million) Table 155. North America AI Clinical Trial Design Software Market Share by Country (2021-2026) Table 156. North America AI Clinical Trial Design Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. North America AI Clinical Trial Design Software Market Share Forecast by Country (2027-2032) Table 158. Europe AI Clinical Trial Design Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe AI Clinical Trial Design Software Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe AI Clinical Trial Design Software Market Share by Country (2021-2026) Table 161. Europe AI Clinical Trial Design Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe AI Clinical Trial Design Software Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific AI Clinical Trial Design Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific AI Clinical Trial Design Software Market Size by Country (2021-2026) & (US$ Million) Table 165. Asia-Pacific AI Clinical Trial Design Software Market Share by Country (2021-2026) Table 166. Asia-Pacific AI Clinical Trial Design Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Asia-Pacific AI Clinical Trial Design Software Market Share Forecast by Country (2027-2032) Table 168. Latin America AI Clinical Trial Design Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Latin America AI Clinical Trial Design Software Market Size by Country (2021-2026) & (US$ Million) Table 170. Latin America AI Clinical Trial Design Software Market Share by Country (2021-2026) Table 171. Latin America AI Clinical Trial Design Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Latin America AI Clinical Trial Design Software Market Share Forecast by Country (2027-2032) Table 173. Middle East & Africa AI Clinical Trial Design Software Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Middle East & Africa AI Clinical Trial Design Software Market Size by Country (2021-2026) & (US$ Million) Table 175. Middle East & Africa AI Clinical Trial Design Software Market Share by Country (2021-2026) Table 176. Middle East & Africa AI Clinical Trial Design Software Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Middle East & Africa AI Clinical Trial Design Software Market Share Forecast by Country (2027-2032) Table 178. Research Programs/Design for This Report Table 179. Authors List of This Report Table 180. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. AI Clinical Trial Design Software Product Image Figure 3. Global AI Clinical Trial Design Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global AI Clinical Trial Design Software Market Size (2021-2032) & (US$ Million) Figure 5. Global AI Clinical Trial Design Software Market Share by Region: 2025 VS 2032 Figure 6. Global AI Clinical Trial Design Software Market Share by Region (2021-2032) Figure 7. North America AI Clinical Trial Design Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe AI Clinical Trial Design Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific AI Clinical Trial Design Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America AI Clinical Trial Design Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa AI Clinical Trial Design Software Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. End-to-End Trial Design Platforms Image Figure 13. Global End-to-End Trial Design Platforms Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Protocol Authoring and Optimization Software Image Figure 15. Global Protocol Authoring and Optimization Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Trial Simulation and Outcome Prediction Software Image Figure 17. Global Trial Simulation and Outcome Prediction Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Adaptive and Bayesian Design Software Image Figure 19. Global Adaptive and Bayesian Design Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Feasibility and Enrollment Design Software Image Figure 21. Global Feasibility and Enrollment Design Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Synthetic Control and Digital Twin Software Image Figure 23. Global Synthetic Control and Digital Twin Software Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Global AI Clinical Trial Design Software Market Size Overview by Type (2021-2032) & (US$ Million) Figure 25. Global AI Clinical Trial Design Software Market Share by Type 2025 VS 2032 Figure 26. North America AI Clinical Trial Design Software Market Size Share by Type (2021-2032) Figure 27. Europe AI Clinical Trial Design Software Market Size Share by Type (2021-2032) Figure 28. Asia-Pacific AI Clinical Trial Design Software Market Size Share by Type (2021-2032) Figure 29. Latin America AI Clinical Trial Design Software Market Size Share by Type (2021-2032) Figure 30. Middle East and Africa AI Clinical Trial Design Software Market Size Share by Type (2021-2032) Figure 31. Pharmaceutical and Biotechnology Companies Image Figure 32. Global Pharmaceutical and Biotechnology Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Contract Research Organizations Image Figure 34. Global Contract Research Organizations Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Medical Device and Diagnostics Companies Image Figure 36. Global Medical Device and Diagnostics Companies Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Academic and Medical Research Institutions Image Figure 38. Global Academic and Medical Research Institutions Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Government and Nonprofit Research Organizations Image Figure 40. Global Government and Nonprofit Research Organizations Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Other Clinical Research Organizations Image Figure 42. Global Other Clinical Research Organizations Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. Global AI Clinical Trial Design Software Market Size Overview by Application (2021-2032) & (US$ Million) Figure 44. Global AI Clinical Trial Design Software Market Share by Application 2025 VS 2032 Figure 45. North America AI Clinical Trial Design Software Market Size Share by Application (2021-2032) Figure 46. Europe AI Clinical Trial Design Software Market Size Share by Application (2021-2032) Figure 47. Asia-Pacific AI Clinical Trial Design Software Market Size Share by Application (2021-2032) Figure 48. Latin America AI Clinical Trial Design Software Market Size Share by Application (2021-2032) Figure 49. Middle East and Africa AI Clinical Trial Design Software Market Size Share by Application (2021-2032) Figure 50. Global Top 5 and 10 AI Clinical Trial Design Software Players Market Share by Revenue in 2025 Figure 51. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 52. North America AI Clinical Trial Design Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 53. North America AI Clinical Trial Design Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 54. North America AI Clinical Trial Design Software Market Share by Country (2021-2032) Figure 55. Europe AI Clinical Trial Design Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe AI Clinical Trial Design Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe AI Clinical Trial Design Software Market Share by Country (2021-2032) Figure 58. Asia-Pacific AI Clinical Trial Design Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Asia-Pacific AI Clinical Trial Design Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific AI Clinical Trial Design Software Market Share by Country (2021-2032) Figure 61. Latin America AI Clinical Trial Design Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America AI Clinical Trial Design Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America AI Clinical Trial Design Software Market Share by Country (2021-2032) Figure 64. Middle East & Africa AI Clinical Trial Design Software Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 65. Middle East & Africa AI Clinical Trial Design Software Market Share by Country: 2021 VS 2025 VS 2032 Figure 66. Middle East & Africa AI Clinical Trial Design Software Market Share by Country (2021-2032) Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • End-to-End Trial Design Platforms
  • Protocol Authoring and Optimization Software
  • Trial Simulation and Outcome Prediction Software
  • Adaptive and Bayesian Design Software
  • Feasibility and Enrollment Design Software
  • Synthetic Control and Digital Twin Software
Applications
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Medical Device and Diagnostics Companies
  • Academic and Medical Research Institutions
  • Government and Nonprofit Research Organizations
  • Other Clinical Research Organizations
Companies covered
  • Cytel
  • TriNetX
  • Saama
  • Simulations Plus
  • Statsols
  • ConcertAI
  • Phesi
  • Faro Health
  • QuantHealth
  • Unlearn
  • MMS
  • Berry Consultants
  • ZS
  • Clinion
  • Nurocor
  • Lindus Health
  • TrialKey
  • Protocol Builder
  • Medidata
  • IQVIA
  • Certara

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global AI Clinical Trial Design Software Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global AI Clinical Trial Design Software Market Size by Region (2021-2032)
  5. 1.4.1 Global AI Clinical Trial Design Software Market Size by Region (2021-2026)
  6. 1.4.2 Global AI Clinical Trial Design Software Market Size by Region (2027-2032)
  7. 1.5 Key Regions AI Clinical Trial Design Software Market Size (2021-2032)
  8. 1.5.1 North America AI Clinical Trial Design Software Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe AI Clinical Trial Design Software Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific AI Clinical Trial Design Software Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America AI Clinical Trial Design Software Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa AI Clinical Trial Design Software Market Size Growth Rate (2021-2032)
2 AI Clinical Trial Design Software Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 End-to-End Trial Design Platforms
  3. 2.1.2 Protocol Authoring and Optimization Software
  4. 2.1.3 Trial Simulation and Outcome Prediction Software
  5. 2.1.4 Adaptive and Bayesian Design Software
  6. 2.1.5 Feasibility and Enrollment Design Software
  7. 2.1.6 Synthetic Control and Digital Twin Software
  8. 2.2 Global AI Clinical Trial Design Software Market Size by Type
  9. 2.2.1 Global AI Clinical Trial Design Software Market Size Overview by Type (2021-2032)
  10. 2.2.2 Global AI Clinical Trial Design Software Historic Market Size Review by Type (2021-2026)
  11. 2.2.3 Global AI Clinical Trial Design Software Market Size Forecasted by Type (2027-2032)
  12. 2.3 Global AI Clinical Trial Design Software Market Size by Regions
  13. 2.3.1 North America AI Clinical Trial Design Software Market Size Breakdown by Type (2021-2026)
  14. 2.3.2 Europe AI Clinical Trial Design Software Market Size Breakdown by Type (2021-2026)
  15. 2.3.3 Asia-Pacific AI Clinical Trial Design Software Market Size Breakdown by Type (2021-2026)
  16. 2.3.4 South America AI Clinical Trial Design Software Market Size Breakdown by Type (2021-2026)
  17. 2.3.5 Middle East and Africa AI Clinical Trial Design Software Market Size Breakdown by Type (2021-2026)
3 AI Clinical Trial Design Software Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Pharmaceutical and Biotechnology Companies
  3. 3.1.2 Contract Research Organizations
  4. 3.1.3 Medical Device and Diagnostics Companies
  5. 3.1.4 Academic and Medical Research Institutions
  6. 3.1.5 Government and Nonprofit Research Organizations
  7. 3.1.6 Other Clinical Research Organizations
  8. 3.2 Global AI Clinical Trial Design Software Market Size by Application
  9. 3.2.1 Global AI Clinical Trial Design Software Market Size Overview by Application (2021-2032)
  10. 3.2.2 Global AI Clinical Trial Design Software Historic Market Size Review by Application (2021-2026)
  11. 3.2.3 Global AI Clinical Trial Design Software Market Size Forecasted by Application (2027-2032)
  12. 3.3 Global AI Clinical Trial Design Software Market Size by Regions
  13. 3.3.1 North America AI Clinical Trial Design Software Market Size Breakdown by Application (2021-2026)
  14. 3.3.2 Europe AI Clinical Trial Design Software Market Size Breakdown by Application (2021-2026)
  15. 3.3.3 Asia-Pacific AI Clinical Trial Design Software Market Size Breakdown by Application (2021-2026)
  16. 3.3.4 South America AI Clinical Trial Design Software Market Size Breakdown by Application (2021-2026)
  17. 3.3.5 Middle East and Africa AI Clinical Trial Design Software Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 AI Clinical Trial Design Software Industry Trends
  2. 4.2 AI Clinical Trial Design Software Industry Drivers
  3. 4.3 AI Clinical Trial Design Software Industry Opportunities and Challenges
  4. 4.4 AI Clinical Trial Design Software Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by AI Clinical Trial Design Software Revenue (2021-2026)
  2. 5.2 Global AI Clinical Trial Design Software Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global AI Clinical Trial Design Software Key Company Headquarters & Area Served
  4. 5.4 Global AI Clinical Trial Design Software Company, Product Type & Application
  5. 5.5 Global AI Clinical Trial Design Software Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global AI Clinical Trial Design Software Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 AI Clinical Trial Design Software Players Market Share by Revenue in 2025
  9. 5.6.3 2025 AI Clinical Trial Design Software Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Cytel
  2. 6.1.1 Cytel Company Information
  3. 6.1.2 Cytel Business Overview
  4. 6.1.3 Cytel AI Clinical Trial Design Software Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Cytel AI Clinical Trial Design Software Product Portfolio
  6. 6.1.5 Cytel Recent Developments
  7. 6.2 TriNetX
  8. 6.2.1 TriNetX Company Information
  9. 6.2.2 TriNetX Business Overview
  10. 6.2.3 TriNetX AI Clinical Trial Design Software Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 TriNetX AI Clinical Trial Design Software Product Portfolio
  12. 6.2.5 TriNetX Recent Developments
  13. 6.3 Saama
  14. 6.3.1 Saama Company Information
  15. 6.3.2 Saama Business Overview
  16. 6.3.3 Saama AI Clinical Trial Design Software Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Saama AI Clinical Trial Design Software Product Portfolio
  18. 6.3.5 Saama Recent Developments
  19. 6.4 Simulations Plus
  20. 6.4.1 Simulations Plus Company Information
  21. 6.4.2 Simulations Plus Business Overview
  22. 6.4.3 Simulations Plus AI Clinical Trial Design Software Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Simulations Plus AI Clinical Trial Design Software Product Portfolio
  24. 6.4.5 Simulations Plus Recent Developments
  25. 6.5 Statsols
  26. 6.5.1 Statsols Company Information
  27. 6.5.2 Statsols Business Overview
  28. 6.5.3 Statsols AI Clinical Trial Design Software Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Statsols AI Clinical Trial Design Software Product Portfolio
  30. 6.5.5 Statsols Recent Developments
  31. 6.6 ConcertAI
  32. 6.6.1 ConcertAI Company Information
  33. 6.6.2 ConcertAI Business Overview
  34. 6.6.3 ConcertAI AI Clinical Trial Design Software Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 ConcertAI AI Clinical Trial Design Software Product Portfolio
  36. 6.6.5 ConcertAI Recent Developments
  37. 6.7 Phesi
  38. 6.7.1 Phesi Company Information
  39. 6.7.2 Phesi Business Overview
  40. 6.7.3 Phesi AI Clinical Trial Design Software Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Phesi AI Clinical Trial Design Software Product Portfolio
  42. 6.7.5 Phesi Recent Developments
  43. 6.8 Faro Health
  44. 6.8.1 Faro Health Company Information
  45. 6.8.2 Faro Health Business Overview
  46. 6.8.3 Faro Health AI Clinical Trial Design Software Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Faro Health AI Clinical Trial Design Software Product Portfolio
  48. 6.8.5 Faro Health Recent Developments
  49. 6.9 QuantHealth
  50. 6.9.1 QuantHealth Company Information
  51. 6.9.2 QuantHealth Business Overview
  52. 6.9.3 QuantHealth AI Clinical Trial Design Software Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 QuantHealth AI Clinical Trial Design Software Product Portfolio
  54. 6.9.5 QuantHealth Recent Developments
  55. 6.10 Unlearn
  56. 6.10.1 Unlearn Company Information
  57. 6.10.2 Unlearn Business Overview
  58. 6.10.3 Unlearn AI Clinical Trial Design Software Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Unlearn AI Clinical Trial Design Software Product Portfolio
  60. 6.10.5 Unlearn Recent Developments
  61. 6.11 MMS
  62. 6.11.1 MMS Company Information
  63. 6.11.2 MMS Business Overview
  64. 6.11.3 MMS AI Clinical Trial Design Software Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 MMS AI Clinical Trial Design Software Product Portfolio
  66. 6.11.5 MMS Recent Developments
  67. 6.12 Berry Consultants
  68. 6.12.1 Berry Consultants Company Information
  69. 6.12.2 Berry Consultants Business Overview
  70. 6.12.3 Berry Consultants AI Clinical Trial Design Software Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Berry Consultants AI Clinical Trial Design Software Product Portfolio
  72. 6.12.5 Berry Consultants Recent Developments
  73. 6.13 ZS
  74. 6.13.1 ZS Company Information
  75. 6.13.2 ZS Business Overview
  76. 6.13.3 ZS AI Clinical Trial Design Software Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 ZS AI Clinical Trial Design Software Product Portfolio
  78. 6.13.5 ZS Recent Developments
  79. 6.14 Clinion
  80. 6.14.1 Clinion Company Information
  81. 6.14.2 Clinion Business Overview
  82. 6.14.3 Clinion AI Clinical Trial Design Software Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Clinion AI Clinical Trial Design Software Product Portfolio
  84. 6.14.5 Clinion Recent Developments
  85. 6.15 Nurocor
  86. 6.15.1 Nurocor Company Information
  87. 6.15.2 Nurocor Business Overview
  88. 6.15.3 Nurocor AI Clinical Trial Design Software Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Nurocor AI Clinical Trial Design Software Product Portfolio
  90. 6.15.5 Nurocor Recent Developments
  91. 6.16 Lindus Health
  92. 6.16.1 Lindus Health Company Information
  93. 6.16.2 Lindus Health Business Overview
  94. 6.16.3 Lindus Health AI Clinical Trial Design Software Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Lindus Health AI Clinical Trial Design Software Product Portfolio
  96. 6.16.5 Lindus Health Recent Developments
  97. 6.17 TrialKey
  98. 6.17.1 TrialKey Company Information
  99. 6.17.2 TrialKey Business Overview
  100. 6.17.3 TrialKey AI Clinical Trial Design Software Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 TrialKey AI Clinical Trial Design Software Product Portfolio
  102. 6.17.5 TrialKey Recent Developments
  103. 6.18 Protocol Builder
  104. 6.18.1 Protocol Builder Company Information
  105. 6.18.2 Protocol Builder Business Overview
  106. 6.18.3 Protocol Builder AI Clinical Trial Design Software Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Protocol Builder AI Clinical Trial Design Software Product Portfolio
  108. 6.18.5 Protocol Builder Recent Developments
  109. 6.19 Medidata
  110. 6.19.1 Medidata Company Information
  111. 6.19.2 Medidata Business Overview
  112. 6.19.3 Medidata AI Clinical Trial Design Software Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Medidata AI Clinical Trial Design Software Product Portfolio
  114. 6.19.5 Medidata Recent Developments
  115. 6.20 IQVIA
  116. 6.20.1 IQVIA Company Information
  117. 6.20.2 IQVIA Business Overview
  118. 6.20.3 IQVIA AI Clinical Trial Design Software Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 IQVIA AI Clinical Trial Design Software Product Portfolio
  120. 6.20.5 IQVIA Recent Developments
  121. 6.21 Certara
  122. 6.21.1 Certara Company Information
  123. 6.21.2 Certara Business Overview
  124. 6.21.3 Certara AI Clinical Trial Design Software Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Certara AI Clinical Trial Design Software Product Portfolio
  126. 6.21.5 Certara Recent Developments
7 North America
  1. 7.1 North America AI Clinical Trial Design Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America AI Clinical Trial Design Software Market Size by Country (2021-2026)
  3. 7.3 North America AI Clinical Trial Design Software Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe AI Clinical Trial Design Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe AI Clinical Trial Design Software Market Size by Country (2021-2026)
  3. 8.3 Europe AI Clinical Trial Design Software Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific AI Clinical Trial Design Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific AI Clinical Trial Design Software Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific AI Clinical Trial Design Software Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America AI Clinical Trial Design Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America AI Clinical Trial Design Software Market Size by Country (2021-2026)
  3. 10.3 South America AI Clinical Trial Design Software Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa AI Clinical Trial Design Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa AI Clinical Trial Design Software Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa AI Clinical Trial Design Software Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst